April Pawluk

April Pawluk

Auto-generated profile, based on publicly available information

April Pawluk

Arc Institute, Palo Alto, USA

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 December 2012 in Nature
Verified
Journal Article
Open access
PDF file
JBJoe Bondy-Denomy
Joe Bondy-Denomy
APApril Pawluk
April Pawluk
KMKaren Maxwell
Karen Maxwell
ADAlan R. Davidson
Alan R. Davidson
Five classes of phage genes are identified that protect phages from CRISPR-mediated bacterial immunity. CRISPR/Cas immune systems, widely distributed in bacteria and Archaea, protect microbial cells from phage attack through the use of small RNAs for sequence-specific detection and neutralization of invading genomes. It has been suggested that 'anti-CRISPR' mechanisms might exist, and here Alan Davidson and colleagues identify phage-encoded factors that inhibit the CRISPR/Cas system. They also find homologues of these genes in Pseudomonas species, indicating that anti-CRISPR elements have a critical role in the evolution of this bacterial pathogen. A widespread system used by bacteria for protection against potentially dangerous foreign DNA molecules consists of the clustered regularly interspaced short palindromic repeats (CRISPR) coupled with cas (CRISPR-associated) genes1. Similar to RNA interference in eukaryotes2, these CRISPR/Cas systems use small RNAs for sequence-specific detection and neutralization of invading genomes3. Here we describe the first examples of genes that mediate the inhibition of a CRISPR/Cas system. Five distinct ‘anti-CRISPR’ genes were found in the genomes of bacteriophages infecting Pseudomonas aeruginosa. Mutation of the anti-CRISPR gene of a phage rendered it unable to infect bacteria with a functional CRISPR/Cas system, and the addition of the same gene to the genome of a CRISPR/Cas-targeted phage allowed it to evade the CRISPR/Cas system. Phage-encoded anti-CRISPR genes may represent a widespread mechanism for phages to overcome the highly prevalent CRISPR/Cas systems. The existence of anti-CRISPR genes presents new avenues for the elucidation of CRISPR/Cas functional mechanisms and provides new insight into the co-evolution of phages and bacteria.

1 December 2016 in Cell
Verified
Journal Article
Closed access
APApril Pawluk
April Pawluk
NANadia Amrani
Nadia Amrani
YZYan Zhang
Yan Zhang
BGBianca Garcia
Bianca Garcia
YHYurima Hidalgo-Reyes
Yurima Hidalgo-Reyes
ADAlan R. Davidson
Alan R. Davidson

13 June 2016 in Nature Microbiology
Verified
Journal Article
Closed access
PDF file
APApril Pawluk
April Pawluk
RSRaymond H.J. Staals
Raymond H.J. Staals
CTCorinda Taylor
Corinda Taylor
BWBridget N.J. Watson
Bridget N.J. Watson
SSSenjuti Saha
Senjuti Saha
ADAlan R. Davidson
Alan R. Davidson

1 May 2014 in mBio
Verified
Journal Article
Open access
PDF file
APApril Pawluk
April Pawluk
JBJoseph Bondy-Denomy
Joseph Bondy-Denomy
VCVivian H W Cheung
Vivian H W Cheung
KMKaren Maxwell
Karen Maxwell
ADAlan R Davidson
Alan R Davidson
CRISPR-Cas systems are one of the most widespread phage resistance mechanisms in prokaryotes. Our lab recently identified the first examples of phage-borne anti-CRISPR genes that encode protein inhibitors of the type I-F CRISPR-Cas system of Pseudomonas aeruginosa . A key question arising from this work was whether there are other types of anti-CRISPR genes. In the current work, we address this question by demonstrating that some of the same phages carrying type I-F anti-CRISPR genes also possess genes that mediate inhibition of the type I-E CRISPR-Cas system of P. aeruginosa . We have discovered four distinct families of these type I-E anti-CRISPR genes. These genes do not inhibit the type I-F CRISPR-Cas system of P. aeruginosa or the type I-E system of Escherichia coli . Type I-E and I-F anti-CRISPR genes are located at the same position in the genomes of a large group of related P. aeruginosa phages, yet they are found in a variety of combinations and arrangements. We have also identified functional anti-CRISPR genes within nonprophage Pseudomonas genomic regions that are likely mobile genetic elements. This work emphasizes the potential importance of anti-CRISPR genes in phage evolution and lateral gene transfer and supports the hypothesis that more undiscovered families of anti-CRISPR genes exist. Finally, we provide the first demonstration that the type I-E CRISPR-Cas system of P. aeruginosa is naturally active without genetic manipulation, which contrasts with E. coli and other previously characterized I-E systems. IMPORTANCE The CRISPR-Cas system is an adaptive immune system possessed by the majority of prokaryotic organisms to combat potentially harmful foreign genetic elements. This study reports the discovery of bacteriophage-encoded anti-CRISPR genes that mediate inhibition of a well-studied subtype of CRISPR-Cas system. The four families of anti-CRISPR genes described here, which comprise only the second group of anti-CRISPR genes to be identified, encode small proteins that bear no sequence similarity to previously studied phage or bacterial proteins. Anti-CRISPR genes represent a newly discovered and intriguing facet of the ongoing evolutionary competition between phages and their bacterial hosts.

26 June 2024 in Nature
Verified
Journal Article
Open access
PDF file
MDMatthew G. Durrant
Matthew G. Durrant
NPNicholas T. Perry
Nicholas T. Perry
JPJames J. Pai
James J. Pai
AJAditya R. Jangid
Aditya R. Jangid
JAJanuka S. Athukoralage
Januka S. Athukoralage
PHPatrick D. Hsu
Patrick D. Hsu
Genomic rearrangements, encompassing mutational changes in the genome such as insertions, deletions or inversions, are essential for genetic diversity. These rearrangements are typically orchestrated by enzymes that are involved in fundamental DNA repair processes, such as homologous recombination, or in the transposition of foreign genetic material by viruses and mobile genetic elements1,2. Here we report that IS110 insertion sequences, a family of minimal and autonomous mobile genetic elements, express a structured non-coding RNA that binds specifically to their encoded recombinase. This bridge RNA contains two internal loops encoding nucleotide stretches that base-pair with the target DNA and the donor DNA, which is the IS110 element itself. We demonstrate that the target-binding and donor-binding loops can be independently reprogrammed to direct sequence-specific recombination between two DNA molecules. This modularity enables the insertion of DNA into genomic target sites, as well as programmable DNA excision and inversion. The IS110 bridge recombination system expands the diversity of nucleic-acid-guided systems beyond CRISPR and RNA interference, offering a unified mechanism for the three fundamental DNA rearrangements—insertion, excision and inversion—that are required for genome design.

21 December 2018 in mBio
Verified
Journal Article
Open access
PDF file
JLJooyoung Lee
Jooyoung Lee
AMAamir Mir
Aamir Mir
AEAlireza Edraki
Alireza Edraki
BGBianca Garcia
Bianca Garcia
NANadia Amrani
Nadia Amrani
ESErik J. Sontheimer
Erik J. Sontheimer
As one of their countermeasures against CRISPR-Cas immunity, bacteriophages have evolved natural inhibitors known as anti-CRISPR (Acr) proteins. Despite the existence of such examples for type II CRISPR-Cas systems, we currently know relatively little about the breadth of Cas9 inhibitors, and most of their direct Cas9 targets are uncharacterized. In this work we identify two new type II-C anti-CRISPRs and their cognate Cas9 orthologs, validate their functionality in vitro and in bacteria, define their inhibitory spectrum against a panel of Cas9 orthologs, demonstrate that they act before Cas9 DNA binding, and document their utility as off-switches for Cas9-based tools in mammalian applications. The discovery of diverse anti-CRISPRs, the mechanistic analysis of their cognate Cas9s, and the definition of Acr inhibitory mechanisms afford deeper insight into the interplay between Cas9 orthologs and their inhibitors and provide greater scope for exploiting Acrs for CRISPR-based genome engineering.